SCHEMBL5689763

SCHEMBL5689763

CN(CCOc1ccccc1)[C@H]1CC[C@H](c2ccc(O)cc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.51
HRH3 Q9Y5N1 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2C9 P11712 1/20 0.44
KCNH2 Q12809 1/20 0.44
ESR1 P03372 6/20 0.43
ESR2 Q92731 4/20 0.42
ESRRB O95718 2/20 0.42
ESRRG P62508 2/20 0.42
MEN1 O00255 1/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
TP53 P04637 1/20 0.42
MAPT P10636 1/20 0.42
KMT2A Q03164 1/20 0.42
HIF1A Q16665 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
PLD2 O14939 1/20 0.42
PGR P06401 1/20 0.42
PLD1 Q13393 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5689760 1.00 KDM4E (0.51) KDM4EHRH3CYP3A4CYP2C9KCNH2
SCHEMBL5689433 0.89 KCNH2 (0.46) KDM4EHRH3CYP3A4CYP2C9KCNH2
SCHEMBL5689429 0.89 KCNH2 (0.46) KDM4EHRH3CYP3A4CYP2C9KCNH2
SCHEMBL5689617 0.89 KCNH2 (0.46) KDM4EHRH3CYP3A4CYP2C9KCNH2
SCHEMBL5689510 0.88 CYP3A4 (0.45) KDM4EHRH3CYP3A4CYP2C9KCNH2
SCHEMBL5689515 0.88 CYP3A4 (0.45) KDM4EHRH3CYP3A4CYP2C9KCNH2
SCHEMBL5690071 0.88 KDM4E (0.49) KDM4EHRH3CYP3A4CYP2C9KCNH2
SCHEMBL5690074 0.88 KDM4E (0.49) KDM4EHRH3CYP3A4CYP2C9KCNH2
SCHEMBL5690113 0.87 CHRNB2 (0.44) KDM4EMEN1ALDH1A1TP53MAPT
SCHEMBL5690120 0.87 CHRNB2 (0.44) KDM4EMEN1ALDH1A1TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0982026-B1 Use of aryl-cyclohexylamine derivatives in the manufacture of NMDA receptor blockers HOFFMANN LA ROCHE (CH) 2006-05-17 EP disclosed
US-6184236-B1 Method of treating a neurodegenerative disease by administering an aryl-cyclohexylamine derivative HOFFMANN-LA ROCHE INC. 2001-02-06 US disclosed
EP-0982026-A2 Use of aryl-cyclohexylamine derivatives in the manufacture of NMDA receptor blockers F. HOFFMANN-LA ROCHE AG (CH) 2000-03-01 EP disclosed